Bill

SB 827

87(R) - 2021
Senate Health and Human Services
House Insurance
Senate Health and Human Services
House Insurance
Health & Human Services
Insurance
Health
Diseases

Contact the Author

Lois Kolkhorst

Phone:

512-463-0118

Capitol Office:

GE.4

Email:

Vote Recommendation

No
  • Negative
  • Neutral
  • Neutral
  • Negative
  • Neutral

Author(s)

Lois Kolkhorst
Carol Alvarado
Paul Bettencourt
C├ęsar J Blanco
Donna Campbell
Sarah Eckhardt
Juan "Chuy" Hinojosa
Joan Huffman
Bryan Hughes
Eddie Lucio Jr.
Jose Menendez
Borris Miles
Angela Paxton
Royce West
Judith Zaffirini

Co-Author(s)

Brandon Creighton
Roland Gutierrez

Sponsor(s)

Eddie Lucio III

Co-Sponsor(s)

Diego Bernal
Celia Israel

Bill Caption

Relating to the health benefit plan cost-sharing requirements for prescription insulin. 

Fiscal Notes

Estimated Two-year Net Impact to General Revenue Related Funds for SB 827, Committee Report 2nd House, Substituted : a NEGATIVE impact of ($1,236,073) through the biennium ending August 31, 2023. 

The bill would make no appropriation but could provide the legal basis for an appropriation of funds to implement the provisions of the bill. 

Bill Analysis

SB 827 would prevent a health benefit plan from imposing a cost-sharing provision for insulin if the total amount the enrollee is required to pay exceeds $25 for a 30-day supply, regardless of the amount or type of insulin needed to fill the enrollee's prescription. Exemptions are provided for certain types of plans. SB 827 would also require a health benefit plan to include at least one insulin from each therapeutic class in the plan's formulary.

Vote Recommendation Notes

SB 827 is a big government solution to high insulin costs which will ultimately hurt consumers. Placing a $25 out of pocket cap on 30 day insulin supplies will only force health benefit plan providers to find other ways to recoup the costs of insulin. This infringes on our free market and limited government principles, therefore we oppose SB 827. 

Contact the Author

Lois Kolkhorst

Phone:

512-463-0118

Capitol Office:

GE.4

Email: